Loading insider details...
Latest Form 4 (Oct 23, 2026): Sale of 36,342 ALLO shares, $48.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 36,342 | $48.7K |
| Sep 15, 2026 | PERRIGO Co plc (PRGO) | Exercise/Conversion | 1,263 | $17.3K |
| Jun 16, 2026 | PERRIGO Co plc (PRGO) | Exercise/Conversion | 976 | $10.7K |
| May 15, 2026 | PERRIGO Co plc (PRGO) | Exercise/Conversion | 7,305 | $79.2K |
| Mar 17, 2026 | PERRIGO Co plc (PRGO) | Grant/Award | 3,024 | n/a |
| Feb 4, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 24,001 | $42.2K |
| Dec 16, 2025 | PERRIGO Co plc (PRGO) | Grant/Award | 2,140 | n/a |
| Nov 14, 2025 | PERRIGO Co plc (PRGO) | Purchase | 7,500 | $106.3K |
| Oct 23, 2025 | Allogene Therapeutics, Inc. (ALLO) | Sale | 36,744 | $46.2K |
| Sep 16, 2025 | PERRIGO Co plc (PRGO) | Grant/Award | 1,263 | n/a |